-transparent.png){kind=logo}
Malonic dialdehyde (MDA) content was studied in 23 patients with CHD due to coronary atherosclerosis, and in 6 with neurocirculatory dystonia without clinical and angiographic signs of CHD. MDA content as an indirect equivalent of cyclic endoperoxides was higher in the platelets, LDL and VLDL in patients with CHD. It may be a cause of TxA2 and PGI2 unbalance in the blood circulation and leads to the activation of thrombus formation, the decrease in the synthesis of "antiatherogenic" biologically active substances, in particular PGI2, thus promoting the development of CHD due to coronary atherosclerosis.
Related Publications
V P Zykova, and
V S Gasilin, and
Kh A Kurdanov, and
E A Bazanov
April 1987,
Vrachebnoe delo,
V P Zykova, and
V S Gasilin, and
Kh A Kurdanov, and
E A Bazanov
October 1973,
Kardiologiia,
V P Zykova, and
V S Gasilin, and
Kh A Kurdanov, and
E A Bazanov
July 1992,
Kardiologiia,
V P Zykova, and
V S Gasilin, and
Kh A Kurdanov, and
E A Bazanov
January 1990,
Ukrainskii biokhimicheskii zhurnal (1978),
V P Zykova, and
V S Gasilin, and
Kh A Kurdanov, and
E A Bazanov
January 1978,
Terapevticheskii arkhiv,
V P Zykova, and
V S Gasilin, and
Kh A Kurdanov, and
E A Bazanov
January 1987,
Laboratornoe delo,
V P Zykova, and
V S Gasilin, and
Kh A Kurdanov, and
E A Bazanov
January 1985,
Vutreshni bolesti,
V P Zykova, and
V S Gasilin, and
Kh A Kurdanov, and
E A Bazanov
January 1986,
Laboratornoe delo,
V P Zykova, and
V S Gasilin, and
Kh A Kurdanov, and
E A Bazanov
January 1975,
Terapevticheskii arkhiv,
V P Zykova, and
V S Gasilin, and
Kh A Kurdanov, and
E A Bazanov
January 1981,
Biofizika,
